Cite

HARVARD Citation

    Kwon, J. et al. (2022). An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy. Annals of clinical and translational neurology. 9 (6), pp. 810-818. [Online]. 
  
Back to record